Head-to-Head

Corcept Therapeutics Inc. vs. Eli Lilly & Co.

CORT

Corcept Therapeutics Inc.

$116.10 -2.03%

VS LLY

Eli Lilly & Co.

$1184.83 +0.12%

Eli Lilly & Co. (LLY) comes out ahead, leading on 8 of 9 compared factors.

Size & Scale

CORTLLY
Market Cap $12.55 billion $1.05 trillion
Revenue (TTM) $741.17 million $79.67 billion
Net Income (TTM) $106.11 million $26.71 billion

LLY leads on 3 of 3 size & scale factors.

Valuation

CORTLLY
P/E Ratio 133.45 39.77
Price / Book 19.86 31.14
Price / Sales 16.93 13.24

LLY leads on 2 of 3 valuation factors.

Profitability

CORTLLY
Net Margin 14.32% 33.53%
Return on Equity 16.79% 78.84%

LLY leads on 2 of 2 profitability factors.

Dividend

CORTLLY
Dividend Yield — 0.58%
Payout Ratio — 23.23

CORT and LLY split the dividend factors evenly.

Risk & Sentiment

CORTLLY
Short Interest 16.06% 1.29%

LLY leads on 1 of 1 risk & sentiment factors.

Dig deeper: CORT overview, CORT financials, LLY overview, LLY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.